ALFACALCIDOL CAPSULES DIN 02523078
Health Canada record
| Active ingredient(s) | ALFACALCIDOL 1 MCG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A11CC03 ALFACALCIDOL |
| Original market date | |
| Current status date | 06-Dec-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Strides Pharma Canada Inc. — licence 3-002485, currently licensed, last inspection rating C (2026-03-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALFACALCIDOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02523051 | ALFACALCIDOL CAPSULES | STRIDES PHARMA CANADA INC | Capsule | ALFACALCIDOL 0.25 MCG | Approved |
| 00474525 | ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Capsule | ALFACALCIDOL 1 MCG | Marketed |
| 02240329 | ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Drops | ALFACALCIDOL 2 MCG | Marketed |
| 02242502 | ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Solution | ALFACALCIDOL 2 MCG | Marketed |
| 00474517 | ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Capsule | ALFACALCIDOL 0.25 MCG | Marketed |
| 02533316 | SANDOZ ALFACALCIDOL | SANDOZ CANADA INCORPORATED | Capsule | ALFACALCIDOL 0.25 MCG | Marketed |
| 02533324 | SANDOZ ALFACALCIDOL | SANDOZ CANADA INCORPORATED | Capsule | ALFACALCIDOL 1 MCG | Marketed |
| 02239431 | ONE-ALPHA | LEO PHARMA INC | Capsule | ALFACALCIDOL 0.5 MCG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27169 | 2021-12-06 | Abbreviated New Drug Submission (ANDS) |
International API supply for ALFACALCIDOL
6 valid EDQM Certificates of Suitability from 6 holders.
Request a quote for ALFACALCIDOL CAPSULES